Cita APA (7a ed.)

KE, S., B, Y., L, S., RH, D., SL, W., HH, Z., . . . MS, S. (2017). Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks. Dove Medical Press.

Cita Chicago Style (17a ed.)

KE, Squires, Young B, Santiago L, Dretler RH, Walmsley SL, Zhao HH, Pakes GE, Ross LL, y Shaefer MS. Response by Gender of HIV-1-infected Subjects Treated with Abacavir/lamivudine Plus Atazanavir, with or Without Ritonavir, for 144 Weeks. Dove Medical Press, 2017.

Cita MLA (8a ed.)

KE, Squires, et al. Response by Gender of HIV-1-infected Subjects Treated with Abacavir/lamivudine Plus Atazanavir, with or Without Ritonavir, for 144 Weeks. Dove Medical Press, 2017.